Filters

PAG1 Antibody, Cy7 Conjugated

PAG1 Antibody, Cy7 Conjugated size: 0.1ml 350

Price 350
Size 0.1ml
Long name Cy7 Conjugated, PAG1 Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationCy7
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenPAG1
SpecificityThis is a highly specific antibody against PAG1
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Immunogen_range340-390/432
Subcellular locationCytoplasm
SourceKLH conjugated synthetic peptide derived from human PAG1
Gene ID number55824
Swiss ProtQ9NWQ8
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background Inhibits immunological synapse formation by preventing dynamic arrangement of lipid raft proteins, May be involved in cell adhesion signaling, Promotes CSK activation and recruitment to lipid rafts, which results in LCK inhibition, Negatively regulates TCR (T-cell antigen receptor)-mediated signaling in T-cells and FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission743nm/767nm
Synonyms PAG CBP
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
ConjugatedThese antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths
Gene targetPAG1 Conjugated
Short name Conjugated, PAG1 Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy7
Alternative name cyanine 7 coupled, phosphoprotein associated with glycosphin this GO lipid microdomains 1 (Antibody to)
Alternative techniqueantibodies
Alternative to gene target PAG1 and IDBG-26542 and ENSG00000076641 and 55824, PAG1 and IDBG-644850 and ENSBTAG00000014026 and 614460, Pag1 and IDBG-131044 and ENSMUSG00000027508 and 94212, Plasma membranes, SH2 domain binding, this GO :0005070 and SH3/SH2 adaptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0007165 and signal transduction and biological process this GO :0007173 and epidermal growth factor receptor signaling pathway and biological process this GO :0009967 and positive regulation of signal transduction and biological process this GO :0016021 and integral component of membrane and cellular component this GO :0035556 and intracellular signal transduction and biological process this GO :0042169 and SH2 domain binding and molecular function this GO :0045121 and membrane raft and cellular component this GO :0050852 and T cell receptor signaling pathway and biological process this GO :0050863 and regulation of T cell activation and biological process this GO :0050868 and negative regulation of T cell activation and biological process, this GO :0005070: SH3/SH2 adaptor activity, this GO :0005070: SH3/SH2 adaptor activity and also this GO :0005515: protein binding and also this GO :0042169: SH2 domain binding, this GO :0005515: protein binding, this GO :0042169: SH2 domain binding, phosphoprotein associated with glycosphin this GO lipid microdomains 1
Identity 30043
Gene PAG1
Long gene name phosphoprotein membrane anchor with glycosphingolipid microdomains 1
Synonyms gene name phosphoprotein associated with glycosphingolipid microdomains 1
Synonyms name Csk-binding protein transmembrane adaptor protein PAG
Locus 8q21, 13
Discovery year 2005-04-25
GenBank acession AF240634
Entrez gene record 55824
Pubmed identfication 10790433
RefSeq identity NM_018440
Havana BLAST/BLAT OTTHUMG00000164592

Subscribe to our Newsletter